Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
From Representative to Business visionary: Private issue Victories25.09.2023 - 2Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial10.12.2025
- 3Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push09.12.2025
- 4Hostages as leverage: Iran's secret demand aimed at crippling Israel's agriculture04.12.2025
- 5Culinary Joys: Investigating Connoisseur Cooking at Home01.01.1
- Flash flooding causes highways to close to and from Eilat
- 5 Arising Professions in Environmentally friendly power
- Manual for Tracking down the Mysterious Cascades in China
- The Significance of Prenuptial Arrangements in Separation Procedures
- Mountain Trekking on a Tight spending plan: Tracking down the Right Bicycle
- The Most Paramount Crossroads in Olympic History
- Manual for extravagance SUVs for seniors
- Building a Maintainable Closet: Individual Excursions in Moral Style
- The Craft of Computerized Detox: Individual Trials
